来源：American Family Physician, 2018, 97(2): 124-125.
摘要
Nebivolol/valsartan (Byvalson) is a combination of a beta(1) adrenergic blocker/nitric oxide producer and an angiotensin receptor blocker (ARB) labeled for the treatment of patients with hypertension.(1-5)
科研之友
微信
新浪微博
Facebook
分享链接
